Schröder R, Klinger H, Lee S K. "Method for the Synthesis of Ruxolitinib Impurity 35" [P]. US Patent, US 9978418 B2, 2022-01-12.
发明人何建平,唐晓军,李文辉. "A Process for Preparing High-Purity Ruxolitinib Impurity 35" [P]. 中国发明专利, 专利号 CN 111066777 A, 授权公告日 2024-06-22.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of 芦可替尼杂质35 in Pharmaceutical Formulations". Environ. Sci. Technol., 2016, 644, (6), 2091-2120.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of 芦可替尼杂质35 as an Impurity". J. Nat. Prod., 2018, 414, (12), 2856-2874.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Ruxolitinib Impurity 35 Using HRMS and NMR". Anal. Chim. Acta, 2016, 1349, 4730-4741.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 芦可替尼杂质35 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2020, 179, (12), 4924-4927.